The global orally disintegrating tablet market size was valued at USD 14.76 billion in 2024 and is projected to grow from USD 16.33 billion in 2025 to USD 28.88 billion by 2033, exhibiting a CAGR of 7 ...
Pharmac is consulting on funding a new progestogen-only oral contraceptive pill called desogestrel (branded as Cerazette) from 1 April 2025. A range of oral contraceptive pills are currently available ...
Nurse practitioner and University of Ottawa professor Patrick O’Byrne works directly with the newly diagnosed and developed the GetAKit program for HIV self-test kits. He attributes the rise in part ...